Two Sigma Investments’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.5M	Buy	4,066,315 +991,192	+32%	+$3.83M	0.01%	1262
2025 Q4	$12.6M	Buy	3,075,123 +624,318	+25%	+$3.09M	0.02%	977
2025 Q3	$12M	Buy	2,450,805 +1,282,992	+110%	+$6.74M	0.02%	858
2025 Q2	$5.91M	Buy	1,167,813 +15,187	+1%	+$74.6K	0.01%	1131
2025 Q1	$6.1M	Sell	1,152,626 -507,883	-31%	-$3.7M	0.01%	1013
2024 Q4	$11.2M	Buy	1,660,509 +63,211	+4%	+$425K	0.03%	697
2024 Q3	$10.5M	Buy	1,597,298 +171,056	+12%	+$1.23M	0.02%	734
2024 Q2	$10.7M	Buy	1,426,242 +529,762	+59%	+$4.62M	0.03%	688
2024 Q1	$8.94M	Buy	896,480 +363,840	+68%	+$4.05M	0.02%	696
2023 Q4	$5.25M	Buy	532,640 +140,315	+36%	+$1M	0.01%	966
2023 Q3	$3M	Buy	+392,325	New	+$3.91M	0.01%	1151
2023 Q2	–	Sell	-208,143	Closed	-$1.39M	–	3234
2023 Q1	$1.39M	Buy	208,143 +135,040	+185%	+$1.07M	﹤0.01%	1673
2022 Q4	$564K	Buy	+73,103	New	+$717K	﹤0.01%	1971
2022 Q2	–	Sell	-200,131	Closed	-$1.43M	–	2883
2022 Q1	$1.43M	Buy	+200,131	New	+$2.13M	﹤0.01%	1506